News | Cardiovascular Business | June 28, 2022

Atlas Healthcare Partners and MedAxiom Announce First-of-its-Kind Cardiovascular ASC Solution

Partnership will transform ASC cardiovascular care delivery and expand patient access 

Together, Atlas and MedAxiom will transform cardiovascular care by expanding access to high quality, patient-centered heart care in ASCs.

Getty Images


June 28, 2022 — – Atlas Healthcare Partners – which specializes in developing and managing ambulatory surgery centers (ASCs) – and MedAxiom – which is dedicated to cardiovascular organizational performance improvement – today announced the formation of a first-of-its-kind cardiovascular-focused ASC company. Together, Atlas and MedAxiom will transform cardiovascular care by expanding access to high quality, patient-centered heart care in ASCs.  

Cardiology, which has long been on the forefront of healthcare innovation by embracing transformative technologies and trends, is seeing a rapid shift of care to ASCs. The new company will collaborate with health systems and physicians to improve patient outcomes, experience, and access to cardiovascular care in ASCs. Atlas will lead ASC development and management while MedAxiom will oversee cardiovascular ASC clinical and operational outcomes.  

Atlas, the fastest growing company in the ASC industry, takes a highly integrated approach with its health system and physician partners by focusing on aligning physicians and ASCs with the health system’s delivery network and strategy.  

“We’re very excited about the opportunity to partner with MedAxiom,” said Aric Burke, Atlas CEO. “MedAxiom has an excellent national reputation as the cardiovascular performance management leader. Together, we will bring a new level of cardiovascular ASC expertise and experience to health systems and physicians throughout the country.”  

As the leader in cardiovascular operational excellence and performance improvement, MedAxiom unites cardiovascular programs, leaders and industry partners to achieve the Quadruple Aim of high-quality outcomes, lower costs, enhanced patient experience and high physician satisfaction. MedAxiom is shaping the future of cardiovascular care by bridging technology, innovation and care delivery.  

“MedAxiom’s mission to transform cardiovascular care and improve heart health requires novel strategies and strong partnerships,” said Jerry Blackwell, MD, MBA, FACC, MedAxiom president and CEO. “With a clear line of vision into the evolution of ASC service lines, Atlas is a proven leader and authority in outpatient care. By coupling Atlas’ extensive ASC experience with MedAxiom’s cardiovascular-specific expertise, health systems and physicians looking to expand into the outpatient procedure space now have a solution.”  

Marc Toth has been named the Atlas Cardiovascular Market president and will lead strategy and business development for the new partnership. The Atlas vice president of Cardiovascular Development, Trey Domann, will lead development efforts with health systems and cardiology groups.  

For more information: www.atlashp.com


Related Content

News | Cardiovascular Business

May 14, 2024 — GE HealthCare, a leading global medical technology, pharmaceutical diagnostics and digital solutions ...

Home May 14, 2024
Home
News | Cardiovascular Business

May 6, 2024 — SMT (Sahajanand Medical Technologies), a leading medical device company at the forefront of innovative ...

Home May 06, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Clinical trials and innovative technology took center stage during the month of April, racking up some record number ...

Home May 03, 2024
Home
News | Cardiovascular Business

April 29, 2024 — Efforts by the American College of Cardiology, the American Heart Association, the Heart Failure ...

Home April 29, 2024
Home
News | Cardiovascular Business

April 9, 2024 — Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as ...

Home April 09, 2024
Home
News | Cardiovascular Business

April 5, 2024 — The Cardiovascular Research Foundation (CRF) has announced New York Valves: The Structural Heart Summit ...

Home April 05, 2024
Home
News | Cardiovascular Business

April 5, 2024 — Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive ...

Home April 05, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is a Top 10 look at the content that was trending during the month of March on dicardiology.com: 1. CLS Health ...

Home April 04, 2024
Home
News | Cardiovascular Business

March 19, 2024 — The American College of Cardiology (ACC) has selected 50 learners for its 2024 – 2025 Clinical Trials ...

Home March 19, 2024
Home
News | Cardiovascular Business

March 19, 2024 — Titan Medical Inc. announced that it has entered into a definitive amalgamation agreement (the ...

Home March 19, 2024
Home
Subscribe Now